What is Healthtech Solutions Inc. (HLTT)?

Healthtech Solutions Inc. (HLTT) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of HLTT?

The current price of HLTT is $0.00. Prices are updated in real time on Stocks360.

What is HLTT's price-to-earnings (PE) ratio?

HLTT's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is HLTT's market capitalization?

HLTT's market capitalization is $10,663.00, placing it in the small-cap tier.

Healthtech Solutions Inc. (HLTT)

Stock analysis · OTC · Healthcare · Medical - Healthcare Information Services

$0.00

Market Cap

$10.66K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.95

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

97.90K

Healthtech Solutions Inc. (HLTT) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $10.66K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.00 2025-11-25 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Healthtech Solutions Inc.

Healthtech Solutions Inc. operates as a life sciences firm through its various subsidiary companies. A primary area of their work involves creating innovative products for the treatment of both acute and chronic wounds, exemplified by AmnioBind. This specific offering is a placental membrane allograft designed to address severe burns and persistent wounds, such as diabetic foot ulcers. Beyond wound care, the company is also engaged in developing advanced ultrasound imaging technology that integrates artificial intelligence for image analysis, intended for applications in diagnosing and treating conditions affecting the chest and musculoskeletal system. Furthermore, Healthtech Solutions is pioneering software designed to electronically compare signals from a healthy heart rhythm with those from a damaged heart, aiming to derive a unique "curative waveform" signal. Established in 2018, the company's headquarters are located in Tuckahoe, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	-0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-0.00×
EV / Sales	0.00×
Earnings Yield	-44713448960.89%
Free Cash Flow Yield	-24047.54%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$3.28M
Revenue (TTM)	$1.69T
Net Income (TTM)	-$4.77T
Free Cash Flow (TTM)	-$2.56M
Net Debt	$3.27M
Working Capital	-$3.36M
Gross Margin	92.66%
Operating Margin	-204.85%
Net Margin	-180.34%
Return on Equity	178994138.08%
Return on Invested Capital	-1041581681.54%